ArticleJournal of immunology (Baltimore, Md. : 1950)2025

Genetic and pharmacological targeting of nicotinic acetylcholine receptor action blocks tumor progression in mouse models of breast cancer.

Matthew A Heard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.